Beam 治疗内幕人员在负面财务报告中出售了大量股票。 Beam Therapeutics insiders sold significant stock shares amid negative financial reports.

开发治疗严重疾病的遗传药物的生物技术公司Beam治疗公司本月内人销售了大量股票。 Beam Therapeutics, a biotech firm developing genetic medicines for serious diseases, saw significant stock sales by insiders this month. Christine Bellon出售了5 674股股票,将她的所有权减少了4.61%,而CEOJohn Evans出售了30 663股股票,将他的股份减少了3.02%。 Christine Bellon sold 5,674 shares, reducing her ownership by 4.61%, while CEO John Evans sold 30,663 shares, decreasing his stake by 3.02%. 该公司最近报告了负面金融指标,市场上限为15.2亿美元。 The company recently reported negative financial metrics and has a market cap of $1.52 billion.